The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine

BACKGROUND: Chloroquine, a quinolone antimalarial drug, is known to potentially inhibit pH-dependent viral replication of the SARS-CoV‑2 infection. Therefore, chloroquine is considered as a treatment option for coronavirus disease 2019 (COVID-19). Chloroquine is known for prolonging the QT interval,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinkeler, F. S., Berger, F. A., Muntinga, H. J., Jansen, M. M. P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346846/
https://www.ncbi.nlm.nih.gov/pubmed/32648153
http://dx.doi.org/10.1007/s12471-020-01462-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346846/
https://www.ncbi.nlm.nih.gov/pubmed/32648153
http://dx.doi.org/10.1007/s12471-020-01462-6

Ejemplares similares